In patients' serum diagnosed with ovarian cancer an increased titer of IgM anti-GD1 was found, the authors pointing out that these antibodies could represent immunological markers associated with ovarian cancer progression [36]. The gene discussed is CD40LG; the disease is ovarian carcinoma.